The treatments for pancreatic cancer totally depend on the stage of the cancer. A particular treatment plan is designed by the oncologists according to the particular condition and specific requirements of the patients. The pancreatic cancer treatment differs significantly from one to another and can include or exclude some stages according to the conditions of the patient. Attempting to determine the stage of the cancer without performing surgery is a critical job and needs expertise as well as experience to be determined in the perfect way. Generally, the pancreatic cancer treatments are based upon the imaging studies, surgical findings and the general state of well-being of the patient.

At first it is determined if the pancreatic cancer appears to be removable by surgery or not. If the cancer has not spread, it is considered resectable or operable.  For unresectable and metastatic pancreatic cancer that has spread to the blood vessels or other organs, surgery cannot be an appropriate solution. In case, the pancreatic cancer is at the resectable stage surgery followed by radiation or chemotherapy can extend the time of survival. For unresectable pancreatic cancer,nonsurgical therapies like chemotherapy and radiation are best suggested. In metastatic stage of pancreatic cancer surgery is used only as a measure for symptom control. Gemcitabine is a drug found effective in treating metastatic pancreatic cancer. Gemcitabine is combined with other medicines like erlotinib, capecitabine, cisplatin or nab-paclitaxel, to provide better results. Another drug FOLFIRINOX is considered as superior to Gemcitabine but due to its high toxicity the drug cannot be used for all the patients. A new drug ABRAXANE has just been approved by FDA for the treatment of pancreatic cancer.